RetinalGenix Technologies (RTGN) Profit After Tax (2020 - 2026)
RetinalGenix Technologies' (RTGN) quarterly Profit After Tax came in at -$590489.0 in Q1 2026, down 0.55% year-on-year from -$593754.7 in Q1 2025, and up 5.24% quarter-over-quarter from -$623127.0 in Q4 2025.
RetinalGenix Technologies (RTGN) Profit After Tax (2020 - 2026) Analysis & Trends
RetinalGenix Technologies has disclosed Profit After Tax across 7 years of filings, most recently posting -$590489.0 for Q1 2026.
- Profit After Tax for Q1 2026 came in at -$590489.0, down 0.55% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.4 million (up 11.96% YoY), and the FY2025 annual result was -$2.4 million, up 43.79% from the prior year.
- Profit After Tax came in at -$590489.0 for Q1 2026 at RetinalGenix Technologies, up from -$623127.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of -$352143.0 in Q2 2023 to a low of -$2.5 million in Q3 2022.
- The 5-year median for Profit After Tax is -$623127.0 (2025), against an average of -$784986.5.
- Across the five-year window, Profit After Tax slumped 354.52% in 2022 and surged 72.63% in 2025, its largest moves.
- RetinalGenix Technologies' Profit After Tax stood at -$674946.0 in 2022, then rose by 19.75% to -$541636.0 in 2023, then tumbled by 60.08% to -$867027.0 in 2024, then climbed by 28.13% to -$623127.0 in 2025, then climbed by 5.24% to -$590489.0 in 2026.
- The last three Profit After Tax figures came in at -$590489.0 (Q1 2026), -$623127.0 (Q4 2025), and -$568791.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.14 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 170.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | RetinalGenix Technologies | - | - | - | -590,489.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -590,489.00 |
| Dec 31, 2025 | -623,127.00 |
| Sep 30, 2025 | -568,791.00 |
| Jun 30, 2025 | -649,418.00 |
| Mar 31, 2025 | -587,259.00 |
| Dec 31, 2024 | -867,027.00 |
| Sep 30, 2024 | -644,291.00 |
| Jun 30, 2024 | -663,633.00 |
| Mar 31, 2024 | -2.15 Mn |
| Dec 31, 2023 | -541,636.00 |
| Sep 30, 2023 | -686,467.00 |
| Jun 30, 2023 | -352,143.00 |
| Mar 31, 2023 | -510,643.00 |
| Dec 31, 2022 | -674,946.00 |
| Sep 30, 2022 | -2.50 Mn |
| Jun 30, 2022 | -359,335.00 |
| Mar 31, 2022 | -375,199.00 |
| Dec 31, 2021 | -409,738.00 |
| Sep 30, 2021 | -551,023.00 |
| Jun 30, 2021 | -534,852.00 |